UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
This guide covers what to know about dividend investing for beginners, offering essential insights to help you succeed in the market.
14,359 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Unlock a practical framework for interpreting bridger aerospace (BAER) earnings. This guide breaks down revenue drive...
Silver has cooled after a sharp rally, but the path ahead remains uncertain. This guide breaks down why silver down f...
AI has redefined market leadership, with Nvidia at the center. But a looming $630 billion warning asks investors to s...
Alphabet's AI ambitions are under scrutiny as cloud momentum and big-capex raise the stakes. Here’s what investors sh...
Cryptio has closed a $45 million Series B to scale its enterprise crypto accounting platform, aiming to help large fi...
A sharp, near-$99 million exit from this cybersecurity stock has analysts buzzing about a possible shift in investor ...
Investors are buzzing about XPeng as xpeng stock winning this week suggests growth catalysts could unfold. This guide...
Big tech pullbacks can create compelling opportunities. This guide examines whether amazon alphabet among best stocks...
In 2026, investors are focusing on profits, not just sales. This guide explains the walmart metric watch 2026 framewo...
As 2026 nears its end, traders ask which asset offers the better upside for a $5,000 bet: Bitcoin or XRP. This report...
A viral Oscars quip turns into a teachable moment about money. This personal finance guide breaks down budgeting, sav...